Cephalon, Inc., (Nasdaq: CEPH) Receives FDA Approval for TREANDA

Tags:
Cephalon FDA Approval Treanda Indolent Non-hodgkin's Lymphoma NHL Cancer Treatments B-cell Patients
MultiVu
  • By: MultiVu
  • Subscribers: 69
  • Updated: 30-Dec-09
  • Videos: 2094
  • International International
  • Comments: 0
  • Views: 110
  • Added: 03-Nov-08

Cephalon, Inc., (Nasdaq: CEPH) today announced that the U.S. Food and Drug Administration (FDA) approved TREANDA

  1. Categories: News & Events
Comments on

Cephalon, Inc., (Nasdaq: CEPH) Receives FDA Approval for TREANDA

0 Comments | Be the first to comment